More about
Metastatic Prostate Cancer
News
February 12, 2021
5 min read
Save
Fewer PSA screenings linked to increases in advanced prostate cancer diagnoses
News
February 01, 2021
1 min read
Save
FDA lifts clinical hold on trial of CAR-T for metastatic pancreatic, prostate cancers
News
October 07, 2020
2 min read
Save
Rucaparib active in BRCA-mutated metastatic castration-resistant prostate cancer
News
September 06, 2020
1 min read
Save
Eight important updates for National Prostate Cancer Awareness Month
News
July 17, 2020
2 min read
Save
New framework takes genetic testing guidelines for prostate cancer ‘a step further’
News
June 14, 2020
1 min read
Save
AACR Academy names president-elect
News
May 15, 2020
1 min read
Save
FDA approves Rubraca for prostate cancer subset
News
April 27, 2020
6 min read
Save
Addition of atezolizumab to enzalutamide fails to extend OS in metastatic castration-resistant prostate cancer

Atezolizumab in combination with enzalutamide did not extend OS compared with enzalutamide monotherapy among men with metastatic castration-resistant prostate cancer, according to results of a randomized phase 3 IMbassador250 study presented at the virtual American Association for Cancer Research Annual Meeting.
News
February 14, 2020
2 min read
Save
HSD3B1 genotype linked to worse outcomes in low-volume metastatic prostate cancer
News
February 12, 2020
2 min read
Save